Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM

Clinical trial NCT04695431 · COMPLETED

Trial details

NCT number: NCT04695431
Sponsor: Blueprint Medicines Corporation
Status: COMPLETED
Study type: OBSERVATIONAL

Advanced Systemic Mastocytosis Aggressive Systemic Mastocytosis Systemic Mastocytosis With an Associated Hematological Neoplasm Mast Cell Leukemia

Start date: 2020-12-02
Primary completion: 2021-10-04
Enrollment: 317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.